ReviewCurrent heart failure reports2015
Cardiohepatic syndrome.
Review in Current heart failure reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed.
- Renal and hepatic function of patients with severe tricuspid regurgitation undergoing inferior caval valve implantation.Scientific reports · 2021Trial
- Incremental prognostic value of hepatic tissue alterations derived from cardiac magnetic resonance imaging for arrhythmogenic right ventricular cardiomyopathy: a case-control study.Quantitative imaging in medicine and surgery · 2026Article
- Impact of cardiohepatic syndrome on postoperative mortality in heart failure patients with reduced ejection fraction undergoing coronary artery bypass grafting.Journal of cardiothoracic surgery · 2026Article
- Prognostic Impact of Combinational Elastography in Patients with Heart Failure.Journal of clinical medicine · 2026Article
- The Relationship Between the Serum Aspartate Aminotransferase/Alanine Aminotransferase Ratio and the Occurrence and Progression of Abdominal Aortic Aneurysms: A Cross-Sectional Study.Brazilian journal of cardiovascular surgery · 2026Article
- Review
- Changes in hepatic and renal Doppler ultrasonography: Current standard therapy in dogs with congestive heart failure.Open veterinary journal · 2025Article
- Transcatheter Tricuspid Valve Replacement Beyond Boundaries.JACC. Case reports · 2025Article
- Effects of transcatheter tricuspid valve replacement on hepatic and renal function in severe TR.International journal of cardiology. Heart & vasculature · 2025Article
- Hepatic Biomarker Abnormalities in the Cardiac Intensive Care Unit: Proposed Criteria for Cardiohepatic Syndrome.JACC. Advances · 2025Article
- Prognostic Role of Ultrasound Diagnostic Methods in Patients with Acute Decompensated Heart Failure.Oman medical journal · 2024Article
- Article
- Amiodarone treatment in cats: evaluation of indications, adverse effects, and survival outcomes.Frontiers in veterinary science · 2024Article
- Prognostic value of fibrosis-5 index combined with C-reactive protein in patients with acute decompensated heart failure.BMC cardiovascular disorders · 2023Article
- Cardio-hepatic syndrome in patients undergoing transcatheter aortic valve replacement.Clinical research in cardiology : official journal of the German Cardiac Society · 2023Article
- Association between Major Adverse Cardiovascular Events and the Liver Fibrosis Score in Patients with and without Coronary Artery Disease: From the FU-CCTA Registry.Journal of clinical medicine · 2023Article
- Intraoperative use of cell saver devices decreases the rate of hyperlactatemia in patients undergoing cardiac surgery.Heliyon · 2023Article
- Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort study.Scientific reports · 2022Article
- Liver fibrosis index as a novel prognostic factor in patients with pulmonary arterial hypertension.Heart and vessels · 2022Article
- Hemosiderin Accumulation in Liver Decreases Iron Availability in Tachycardia-Induced Porcine Congestive Heart Failure Model.International journal of molecular sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulating evidence shows that acute as well as chronic heart disease can directly contribute to an acute or chronic worsening of liver function and vice versa. Description and definition of cardiohepatic syndrome (CHS) in this review are based on the cardiorenal syndrome (CRS) concept. The eye-catching analogy between CHS and CRS is applied to facilitate an understanding of the pathophysiology and overall burden of disease for each of the proposed CHS subtypes, their natural course, and associated morbidity and mortality.
Indexed as
Identifiers
25391350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.